Susquehanna International Group, LLP Capricor Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 46,015 shares of CAPR stock, worth $326,246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,015
Previous 168,988
72.77%
Holding current value
$326,246
Previous $1.6 Million
71.55%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding CAPR
# of Institutions
143Shares Held
12.4MCall Options Held
4.99MPut Options Held
5.52M-
Vanguard Group Inc Valley Forge, PA2.31MShares$16.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$11.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$10.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$6.83 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$3.9 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $173M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...